Efficacy and safety of VR475 (budesonide suspension delivered by the VR475 Inhalation System) as add-on treatment in patients with severe asthma (CLEARCUT Study)

Conclusions: VR475 did not significantly reduce the CSE rate in this severe uncontrolled asthma population. However, the cortisol and PK data, together with better spirometry results indicate an improved budesonide delivery to the lung with VR475 Inhalation system vs CN.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Airway pharmacology and treatment Source Type: research